NCT02849171View on ClinicalTrials.gov

Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 6, 2022

Study Completion Date

May 6, 2022

Conditions
Brain Cancer
Interventions
DEVICE

PET scan

RADIATION

C-Choline

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02849171 - Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas | Biotech Hunter | Biotech Hunter